1. Challenges to the Economic Evaluation of New Biotechnological Interventions in Healthcare

   • James Mason

   Current Opinion 22 September 2012 Pages: 119 - 125

2. A Review of Quality-of-Life Evaluations in Prostate Cancer

   • Sunshine D. Sommers
   • Scott D. Ramsey

   Review Article 22 September 2012 Pages: 127 - 140

3. Review of Quality-of-Life Evaluations in Patients with Angina Pectoris

   • Afschin Gandjour
   • Karl W. Lauterbach

   Review Article 22 September 2012 Pages: 141 - 152

4. Cost Effectiveness of Riluzole in Amyotrophic Lateral Sclerosis

   • Andrea Messori
   • Sabrina Trippoli
   • Gaetano Zaccara

   Original Research Article 22 September 2012 Pages: 153 - 163

5. Estimating Long Term Cost Savings from Treatment of Alzheimer’s Disease

   • Paul Fenn
   • Alastair Gray

   Original Research Article 22 September 2012 Pages: 165 - 174

6. The Influence of Hospital-Based Prescribers on Prescribing in General Practice

   • John Feely
   • Robert Chan
   • Brendan O’Shea

   Original Research Article 22 September 2012 Pages: 175 - 181

7. Cost Comparison of Antibacterial Therapies for Serious Infections

   • Guy Scott
   • Helen M. Scott
   • Philippa Cotterell

   Original Research Article 22 September 2012 Pages: 183 - 192

8. Choice of Cost-Effectiveness Measure in the Economic Evaluation of Cholesterol-Modifying Pharmacotherapy

   • Stephen Morris
   • Ed Godber

   Original Research Article 22 September 2012 Pages: 193 - 205